482 related articles for article (PubMed ID: 27473669)
21. [Factors related to biologic behavior in giant cell tumor of bone].
Ran XY; Huang J; Zhang HZ; Jiang ZM; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):669-74. PubMed ID: 24433729
[TBL] [Abstract][Full Text] [Related]
22. Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?
Hegde V; Burke ZDC; Park HY; Zoller SD; Johansen D; Kelley BV; Levine B; Motamedi K; Federman NC; Seeger LL; Nelson SD; Bernthal NM
Clin Orthop Relat Res; 2018 Mar; 476(3):568-577. PubMed ID: 29529643
[TBL] [Abstract][Full Text] [Related]
23. Fine needle aspiration diagnosis of aggressive giant cell tumor of bone. A case report.
Ríos-Martín J; Otal-Salaverri C; Vázquez-Ramírez FJ; González-Cámpora R; Davidson HG
Acta Cytol; 1995; 39(3):550-4. PubMed ID: 7762351
[TBL] [Abstract][Full Text] [Related]
24. Conditions that mimic osteosarcoma.
Raymond AK; Jaffe N
Cancer Treat Res; 2009; 152():85-121. PubMed ID: 20213387
[TBL] [Abstract][Full Text] [Related]
25. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
26. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
Ratnagiri R; Uppin S
J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
[TBL] [Abstract][Full Text] [Related]
27. Treatment and differential diagnosis of aneurysmal bone cyst based on our own experience.
Tomasik P; Spindel J; Miszczyk L; Chrobok A; Koczy B; Widuchowski J; Mrozek T; Matysiakiewicz J; Pilecki B
Ortop Traumatol Rehabil; 2009; 11(5):467-75. PubMed ID: 19920289
[TBL] [Abstract][Full Text] [Related]
28. Giant cell rich osteosarcoma revisited-diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment.
Chow LT
Virchows Arch; 2016 Jun; 468(6):741-55. PubMed ID: 27003154
[TBL] [Abstract][Full Text] [Related]
29. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
Davis JL; Horvai AE
Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
[TBL] [Abstract][Full Text] [Related]
30. [Differential diagnosis of giant cell tumors].
Protsenko VV
Lik Sprava; 2003 Dec; (8):55-9. PubMed ID: 14965008
[TBL] [Abstract][Full Text] [Related]
31. Keratin-Positive Giant Cell-Rich Tumor of Bone Harboring an
Patton A; Ilaslan H; Armstrong SM; Bakhshwin A; Cheng YW; Minhas F; Fritchie KJ
Int J Surg Pathol; 2024 May; 32(3):556-564. PubMed ID: 37461232
[TBL] [Abstract][Full Text] [Related]
32. [Giant cell-rich lesions of bone and their differential diagnosis].
Zambo I; Pazourek L
Cesk Patol; 2017; 53(2):61-70. PubMed ID: 28597667
[TBL] [Abstract][Full Text] [Related]
33. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
Akpalo H; Lange C; Zustin J
Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
[TBL] [Abstract][Full Text] [Related]
34. [Giant cell-containing tumors of bone and differential diagnoses].
Heitkötter B; Hartmann W
Pathologe; 2022 May; 43(3):174-182. PubMed ID: 35467097
[TBL] [Abstract][Full Text] [Related]
35. Alphabet soup: cystic lesions of bone.
Parman LM; Murphey MD
Semin Musculoskelet Radiol; 2000; 4(1):89-101. PubMed ID: 11061694
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
Hoshi M; Takada J; Oebisu N; Hata K; Ieguchi M; Nakamura H
Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642
[TBL] [Abstract][Full Text] [Related]
37. p63 as a prognostic marker for giant cell tumor of bone.
Yanagisawa M; Kakizaki H; Okada K; Torigoe T; Kusumi T
Ups J Med Sci; 2013 Mar; 118(1):23-8. PubMed ID: 23033898
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group.
Sciot R; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Tallini G; Van den Berghe H; Vanni R; Willén H
Mod Pathol; 2000 Nov; 13(11):1206-10. PubMed ID: 11106078
[TBL] [Abstract][Full Text] [Related]
39. Histopathology of giant cell tumors of the bone: With special emphasis on fibrohistiocytic and aneurysmal bone cyst like components.
Çomunoğlu N; Kepil N; Dervişoğlu S
Acta Orthop Traumatol Turc; 2019 Jan; 53(1):35-39. PubMed ID: 30392920
[TBL] [Abstract][Full Text] [Related]
40. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
